Evidence map›Paper›PMID 35288252›Full record

ArticleThe Journal of hospital infection2022

Risk of SARS-CoV-2 transmission upon return to work in RNA-positive healthcare workers.

L M Kolodziej, S Hordijk, J Koopsen, J J Maas, H T Thung, I J B Spijkerman, M Jonges, M K Bomers, J J Sikkens, M D de Jong and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of hospital infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Low SARS-CoV-2 Cq values in healthcare workers with symptomatic COVID-19 infections, regardless of symptom severity, The Netherlands, January to August 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

L M KolodziejDepartment of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: l.m.kolodziej@amsterdamumc.nl.
S HordijkDepartment of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands.
J KoopsenDepartment of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands.
J J MaasDepartment of Occupational Health, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands.
H T ThungDepartment of Occupational Health, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands.
I J B SpijkermanDepartment of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands.
M JongesDepartment of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands.
M K BomersDepartment of Internal Medicine, Division of Infectious Diseases, Amsterdam University Medical Centres, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
J J SikkensDepartment of Internal Medicine, Division of Infectious Diseases, Amsterdam University Medical Centres, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
M D de JongDepartment of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands.
R ZonneveldDepartment of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands.
J SchinkelDepartment of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands.
Amsterdam University Medical Centers · NLUniversity of Amsterdam · NLVrije Universiteit Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealthcare workers (HCWs) are at risk for coronavirus disease 2019 (COVID-19), and for spreading severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) amongst colleagues and patients.

aimTo study the presence of SARS-CoV-2 RNA and possible onward transmission by HCWs upon return to work after COVID-19, and association with disease severity and development of antibodies over time.

methodsUnvaccinated HCWs with positive SARS-CoV-2 reverse transcriptase polymerase chain reaction (RT-PCR) were recruited prospectively. Data on symptoms were collected via telephone questionnaires on days 2, 7, 14 and 21 after a positive test. Upon return to work, repeat SARS-CoV-2 RT-PCR was performed and serum was collected. Repeat serum samples were collected at weeks 4, 8, 12 and 16 to determine antibody dynamics over time. Phylogenetic analysis was conducted to investigate possible transmission events originating from HCWs with a positive repeat RT-PCR.

findingsSixty-one (84.7%) participants with mild/moderate COVID-19 had a repeat SARS-CoV-2 RT-PCR performed upon return to work (median 13 days after symptom onset), of which 30 (49.1%) were positive with a median cycle threshold (Ct) value of 29.2 (IQR 26.9-29.9). All HCWs developed antibodies against SARS-CoV-2. No significant differences in symptomatology and presence of antibodies were found between repeat RT-PCR-positive and -negative HCWs. Eleven direct colleagues of six participants with a repeat RT-PCR Ct value <30 tested positive after the HCW returned to work. Phylogenetic and epidemiologic analysis did not indicate onward transmission through HCWs who were SARS-CoV-2 RNA positive upon return to work.

conclusionsHCWs regularly return to work with substantial SARS-CoV-2 RNA loads. However, this study found no evidence for subsequent in-hospital transmission.

Indexed as

COVID-19SARS-CoV-2Health PersonnelHumansPhylogenyReturn to WorkRNA, ViralRNA, ViralCOVID-19Healthcare workerInfectious disease transmissionSARS-CoV-2

Identifiers

PMID35288252
PMCPMC8916832
OpenAlexW4220843184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.